The first thing you notice about ADA Biotech's straws is what they are not made of. They are not plastic, nor are they the typical paper or PLA. They are, according to the company, a composite of broken rice, wheat pollard, palm kernel residues, and other agricultural leftovers that would otherwise be waste [ADA Biotech site, undated]. For founder Akmal Amir, who started the company in 2019, the goal was straightforward: replace single-use plastics with something that disappears, using the materials already piling up around him in Malaysia [ADA Biotech site, undated]. The business, however, is less about a moral statement and more about a simple unit economics question. Can you make a certified, affordable straw from waste that a food service company will buy?
The wedge of waste and certification
ADA Biotech's answer hinges on two things: a low-cost feedstock and a wall of certifications. The company sources rice husks, wheat pollard, and palm kernel from local agricultural processors, turning a disposal problem into a raw material [The Sun, 2024]. Its production process, which it describes as using Industrial 4.0 technology and AI robotics, is designed to keep costs down [Venture Grab, 2023]. On the other side, it has assembled a stack of approvals that matter in global food supply chains: Halal, FDA, ISO 22000, BRC, and Gluten Free [Venture Grab, 2023]. This combination is the wedge. The product is not positioned as a premium artisan item but as a direct, compliant replacement for the plastic straws currently shipped by the millions.
Traction and the search for scale
The company reports its production capacity is fully booked, though it does not name the customers filling those lines [The Sun, 2024]. Public revenue figures show modest, early-stage growth: RM 1.1 million (approximately $235,000) in 2022, with a projection of RM 2.4 million (approximately $515,000) by the end of 2023 [Venture Grab, 2023]. It has also expanded its product line beyond straws into biocomposites and even a cat litter product [LinkedIn Akmal Amir, undated]. A recent development is a partnership with Masverse Technologies to integrate blockchain technology into its eco-friendly rice straw products, ostensibly for supply chain traceability [MalaysiaKini, undated]. The most concrete signal of momentum is a recent win: the Judges' Favourite prize at the Cyberview Living Lab Accelerator demo day in 2025 [BusinessToday, 2025].
The funding gap and competitive landscape
Despite the booked capacity and prize, ADA Biotech remains a largely self-funded operation with, it claims, zero bank borrowings [Venture Grab, 2023]. It is actively seeking its first external investment: RM 2 million (approximately $430,000) at a RM 20 million pre-money valuation, listed on a business sale platform [Venture Grab, 2023]. This capital is intended to install new machinery and further reduce production costs. The ask highlights the central challenge of scaling a capital-intensive manufacturing business. The competitive field in Southeast Asia includes players like Verdastro, Eco Touch, and Green Eco Paradise. The table below outlines the known landscape.
| Company | Primary Focus | Known Differentiation |
|---|---|---|
| ADA Biotech | Biodegradable straws & biocomposites | Waste-derived feedstock, broad certifications |
| Verdastro | Not specified | Not specified in available sources |
| Eco Touch | Not specified | Not specified in available sources |
| Green Eco Paradise | Not specified | Not specified in available sources |
For ADA Biotech, the path forward involves several interconnected bets. The company must:
- Prove named demand. "Production fully booked" is a strong signal, but without disclosed customer logos, it remains an internal metric.
- Scale with capital efficiency. The sought-after RM 2 million is a small round for heavy machinery; the cost-reduction targets will need to be hit precisely.
- Expand beyond straws. The biocomposites and cat litter suggest a platform play, but they also dilute focus in a capital-constrained environment.
- use the blockchain narrative. The Masverse partnership is a press-friendly move, but its real value will be measured by whether it attracts premium buyers or streamlines logistics.
A back-of-the-envelope calculation puts the ambition in perspective. If ADA Biotech hit its 2023 revenue projection (~$515,000) and sold straws at an estimated bulk price of $0.01 each, that would represent over 50 million straws. That's a lot of rice husk. The incumbent it must beat isn't another green startup; it's the entrenched, global supply chain for cheap plastic straws. The bet is that a certified, biodegradable alternative, born from local waste, can be just as cheap and reliable. For now, the factory lines are running. The next step is to show who's buying, and prove the unit economics can travel beyond Malaysia.
Sources
- [ADA Biotech site, undated] About - ADABIOTECH | https://www.adabiotech.com/about/
- [The Sun, 2024] ADA Biotech strengthens production capacity, supply chain partnerships to support growth | https://thesun.my/business/ada-biotech-strengthens-production-capacity-supply-chain-partnerships-to-support-growth-he14892234/
- [Venture Grab, 2023] ADA Biotech Sdn Bhd | Business Listing | https://www.venturegrab.com/business/ada-biotech-sdn-bhd/
- [LinkedIn Akmal Amir, undated] Akmal Amir | LinkedIn | https://www.linkedin.com/in/akmalamir/
- [MalaysiaKini, undated] Integrating Blockchain Technology into Eco-Friendly Rice Straw Products, Masverse Technologies Partners with ADA Biotech | https://www.malaysiakini.com/announcement/696698
- [BusinessToday, 2025] ADA Biotech Wins Judges' Favourite At Cyberview Demo Day | https://www.businesstoday.com.my/2025/07/11/ada-biotech-wins-judges-favourite-at-cyberview-demo-day/